Literature DB >> 12870890

Interaction of trivalent arsenicals with metallothionein.

Guifeng Jiang1, Zhilong Gong, Xing-Fang Li, William R Cullen, X Chris Le.   

Abstract

Arsenic is a human carcinogen, causing skin, bladder, and lung cancers. Although arsenic in drinking water affects millions of people worldwide, the mechanism(s) of action by which arsenic causes cancers is not known. Arsenic probably exerts some toxic effects by binding with proteins. However, few experimental data are available on arsenic-containing proteins in biological systems. This study reports on arsenic interaction with metallothionein and established binding stoichiometries between metallothionein and the recently discovered trivalent metabolites of arsenic metabolism. Size exclusion chromatography with inductively coupled plasma mass spectrometry analysis of reaction mixtures between trivalent arsenicals and metallothionein clearly demonstrated the formation of complexes of arsenic with metallothionein. Analysis of the complexes using electrospray quadrupole time-of-flight tandem mass spectrometry revealed the detailed binding stoichiometry between arsenic and the 20 Cys residues in the metallothionein molecule. Inorganic arsenite (As(III)) and its two trivalent methylation metabolites, monomethylarsonous acid (MMA(III)) and dimethylarsinous acid (DMA(III)), readily bind with metallothionein. Each metallothionein molecule could bind with up to six As(III), 10 MMA(III), and 20 DMA(III) molecules, consistent with the coordination chemistry of these arsenicals. The findings on arsenic interaction with proteins are useful for a better understanding of arsenic health effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870890     DOI: 10.1021/tx034053g

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  19 in total

1.  Studying arsenite-humic acid complexation using size exclusion chromatography-inductively coupled plasma mass spectrometry.

Authors:  Guangliang Liu; Yong Cai
Journal:  J Hazard Mater       Date:  2012-05-17       Impact factor: 10.588

2.  Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.

Authors:  Elspeth M Beauchamp; Lymor Ringer; Gülay Bulut; Kamal P Sajwan; Michael D Hall; Yi-Chien Lee; Daniel Peaceman; Metin Ozdemirli; Olga Rodriguez; Tobey J Macdonald; Chris Albanese; Jeffrey A Toretsky; Aykut Uren
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  Combined ion-mobility and mass-spectrometry investigations of metallothionein complexes using a tandem mass spectrometer with a segmented second quadrupole.

Authors:  Yuzhu Guo; Yun Ling; Bruce A Thomson; K W Michael Siu
Journal:  J Am Soc Mass Spectrom       Date:  2005-09-22       Impact factor: 3.109

4.  Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1.

Authors:  Wei Qu; Lida Cheng; Anna L Dill; Joseph E Saavedra; Sam Y Hong; Larry K Keefer; Michael P Waalkes
Journal:  Chem Biol Interact       Date:  2011-05-20       Impact factor: 5.192

5.  Speciation, formation, stability and analytical challenges of human arsenic metabolites.

Authors:  Lucy Yehiayan; Mahesh Pattabiraman; Konstantinos Kavallieratos; Xiaotang Wang; Lawrence H Boise; Yong Cai
Journal:  J Anal At Spectrom       Date:  2009-07-21       Impact factor: 4.023

6.  Cadmium in blood of Tunisian men and risk of bladder cancer: interactions with arsenic exposure and smoking.

Authors:  Molka Feki-Tounsi; Pablo Olmedo; Fernando Gil; Rim Khlifi; Mohamed-Nabil Mhiri; Ahmed Rebai; Amel Hamza-Chaffai
Journal:  Environ Sci Pollut Res Int       Date:  2013-05-15       Impact factor: 4.223

7.  Arsenite-induced ROS/RNS generation causes zinc loss and inhibits the activity of poly(ADP-ribose) polymerase-1.

Authors:  Feng Wang; Xixi Zhou; Wenlan Liu; Xi Sun; Chen Chen; Laurie G Hudson; Ke Jian Liu
Journal:  Free Radic Biol Med       Date:  2013-04-18       Impact factor: 7.376

8.  The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis.

Authors:  Wei Qu; Jie Liu; Richard Fuquay; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Lett       Date:  2007-07-20       Impact factor: 8.679

9.  V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity.

Authors:  Wei Qu; Jie Liu; Anna L Dill; Joseph E Saavedra; Larry K Keefer; Michael P Waalkes
Journal:  Cancer Sci       Date:  2008-12-15       Impact factor: 6.716

10.  Microtubules as a critical target for arsenic toxicity in lung cells in vitro and in vivo.

Authors:  Yinzhi Zhao; Paul Toselli; Wande Li
Journal:  Int J Environ Res Public Health       Date:  2012-02-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.